Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity ; volume:28 ; number:1 ; day:11 ; month:10 ; year:2023 ; pages:1-8 ; date:12.2023
European journal of medical research ; 28, Heft 1 (11.10.2023), 1-8, 12.2023

Creator: Thiruvengadam, Ramachandran
Rizvi, Zaigham Abbas
Raghavan, Sreevatsan
Murugesan, Deepika Rathna
Gosain, Mudita
Dandotiya, Jyotsna
Ayushi
Samal, Sweety
Pandey, Anil K.
Wadhwa, Nitya
Bhatnagar, Shinjini
Awasthi, Amit
Garg, Pramod Kumar

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40001-023-01373-3

URN: urn:nbn:de:101:1-2024020113522413934800

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:30 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Thiruvengadam, Ramachandran
Rizvi, Zaigham Abbas
Raghavan, Sreevatsan
Murugesan, Deepika Rathna
Gosain, Mudita
Dandotiya, Jyotsna
Ayushi
Samal, Sweety
Pandey, Anil K.
Wadhwa, Nitya
Bhatnagar, Shinjini
Awasthi, Amit
Garg, Pramod Kumar
SpringerLink (Online service)

Other Objects (12)

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents

Possibility of COVID-19 eradication with evolution of a new omicron variant

Household transmission of the SARS-CoV-2 Omicron variant in Denmark

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents

Possibility of COVID-19 eradication with evolution of a new omicron variant

Household transmission of the SARS-CoV-2 Omicron variant in Denmark

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents

Possibility of COVID-19 eradication with evolution of a new omicron variant

Household transmission of the SARS-CoV-2 Omicron variant in Denmark

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents

Possibility of COVID-19 eradication with evolution of a new omicron variant

Household transmission of the SARS-CoV-2 Omicron variant in Denmark

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents

Possibility of COVID-19 eradication with evolution of a new omicron variant

Household transmission of the SARS-CoV-2 Omicron variant in Denmark

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant SARS-CoV-2 isolates

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents

Possibility of COVID-19 eradication with evolution of a new omicron variant

Household transmission of the SARS-CoV-2 Omicron variant in Denmark

Related objects

Reset password